SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-16-000044
Filing Date
2016-09-08
Accepted
2016-09-08 16:31:05
Documents
55
Period of Report
2016-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q peregrine_10q-073116.htm 10-Q 302111
2 CERTIFICATION peregrine_10q-ex3101.htm EX-31.1 7667
3 CERTIFICATION peregrine_10q-ex3102.htm EX-31.2 8002
4 CERTIFICATION peregrine_10q-ex32.htm EX-32 5440
  Complete submission text file 0001683168-16-000044.txt   2389075

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pphm-20160731.xml EX-101.INS 427348
6 XBRL SCHEMA FILE pphm-20160731.xsd EX-101.SCH 26900
7 XBRL CALCULATION FILE pphm-20160731_cal.xml EX-101.CAL 46704
8 XBRL DEFINITION FILE pphm-20160731_def.xml EX-101.DEF 84747
9 XBRL LABEL FILE pphm-20160731_lab.xml EX-101.LAB 193389
10 XBRL PRESENTATION FILE pphm-20160731_pre.xml EX-101.PRE 167878
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 161876515
SIC: 2834 Pharmaceutical Preparations